These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 1842475)
1. Successful treatment of erectile disfunction with Fortisex coated tablets. Papp G; Kopa Z Acta Chir Hung; 1991; 32(3):229-32. PubMed ID: 1842475 [TBL] [Abstract][Full Text] [Related]
2. Treatment for potency problems with Afrodor 2000. Baumbusch F; Papp GK; Kopa ZS Acta Chir Hung; 1995-1996; 35(1-2):87-92. PubMed ID: 8659243 [TBL] [Abstract][Full Text] [Related]
3. Effect of testosterone supplementation on sexual function in hypogonadal men with erectile dysfunction. Mulhall JP; Valenzuela R; Aviv N; Parker M Urology; 2004 Feb; 63(2):348-52; discussion 352-3. PubMed ID: 14972487 [TBL] [Abstract][Full Text] [Related]
4. [Testosterone and impotence--when is androgen substitution advisable?]. John H Ther Umsch; 1998 Jun; 55(6):372-6. PubMed ID: 9658979 [TBL] [Abstract][Full Text] [Related]
5. Testosterone and erectile physiology. Guay AT Aging Male; 2006 Dec; 9(4):201-6. PubMed ID: 17178555 [TBL] [Abstract][Full Text] [Related]
6. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer. DiBlasio CJ; Malcolm JB; Derweesh IH; Womack JH; Kincade MC; Mancini JG; Ogles ML; Lamar KD; Patterson AL; Wake RW BJU Int; 2008 Jul; 102(1):39-43. PubMed ID: 18294309 [TBL] [Abstract][Full Text] [Related]
7. [Corpus cavernosum injection treatment of erectile impotence]. Lenk S; Schönherr G; Korner I Z Urol Nephrol; 1990 Oct; 83(10):539-46. PubMed ID: 2095661 [TBL] [Abstract][Full Text] [Related]
8. The effect of topically applied vasoactive agents and testosterone versus testosterone in the treatment of erectile dysfunction in aged men with low sexual interest. Gomaa A; Eissa M; El-Gebaley A Int J Impot Res; 2001 Apr; 13(2):93-9. PubMed ID: 11426345 [TBL] [Abstract][Full Text] [Related]
9. [Experience in the treatment of erectile impotence by the intracavernous auto-injection of vasoactive substances]. Ferrière JM; Gaston R; Piechaud T; Le Guillou M Ann Urol (Paris); 1988; 22(1):57-9. PubMed ID: 3369847 [TBL] [Abstract][Full Text] [Related]
10. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy. Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836 [TBL] [Abstract][Full Text] [Related]
11. [A trial of the use pf prostaglandin E1 (Edex, Caverject) for the diagnosis and treatment of erectile dysfunction]. Kovalev VA; Koroleva SV Urol Nefrol (Mosk); 1997; (2):41-4. PubMed ID: 9206883 [TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of Korean red ginseng for erectile dysfunction. Choi HK; Seong DH; Rha KH Int J Impot Res; 1995 Sep; 7(3):181-6. PubMed ID: 8750052 [TBL] [Abstract][Full Text] [Related]
13. [Possibilities of treatment of erectile disorders by the administration of vasoactive substances into the penis using iontophoresis]. Babula V; Sedmík J; Zvĕrina J Cas Lek Cesk; 1989 Oct; 128(43-44):1367-8. PubMed ID: 2598251 [TBL] [Abstract][Full Text] [Related]
14. Biweekly intracavernous administration of papaverine for erectile dysfunction. Mooradian AD; Morley JE; Kaiser FE; Davis SS; Viosca SP; Korenman SC West J Med; 1989 Nov; 151(5):515-7. PubMed ID: 2603417 [TBL] [Abstract][Full Text] [Related]
15. [A new pathogenetic approach and a method of erectile dysfunction treatment and prevention--modulated erectile oxygenation of penile cavernous tissue]. Segal AS; Pushkar' DIu Urologiia; 2004; (5):48-51. PubMed ID: 15560163 [TBL] [Abstract][Full Text] [Related]
16. Correlation of improved erectile function and rate of successful intercourse with improved emotional well-being assessed with the Self-Esteem And Relationship questionnaire in men treated with sildenafil for erectile dysfunction and stratified by age. Steidle CP; Stecher VJ; Pace C; Tseng LJ; Curr Med Res Opin; 2006 May; 22(5):939-48. PubMed ID: 16709315 [TBL] [Abstract][Full Text] [Related]
17. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction. Bratus D; Hlebic G; Hajdinjak T Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142 [TBL] [Abstract][Full Text] [Related]
18. Yohimbine treatment of organic erectile dysfunction in a dose-escalation trial. Guay AT; Spark RF; Jacobson J; Murray FT; Geisser ME Int J Impot Res; 2002 Feb; 14(1):25-31. PubMed ID: 11896474 [TBL] [Abstract][Full Text] [Related]
19. [New principle in therapy of erectile dysfunction: sildenafil]. Weidmann P Ther Umsch; 1998 Jun; 55(6):384-8. PubMed ID: 9658982 [TBL] [Abstract][Full Text] [Related]
20. Postoperative erectile dysfunction; evaluation and treatment with intracavernous vasoactive injections. Sparwasser C; Treiber U; Bahren W; Gall H; Holzki G; Scherb W Prog Clin Biol Res; 1991; 370():349-54. PubMed ID: 1924468 [No Abstract] [Full Text] [Related] [Next] [New Search]